Yves Cornellier
Founder at Alethia Biotherapeutics, Inc.
Profile
Yves Cornellier founded Alethia Biotherapeutics, Inc. in 2002, where he is working as President, Chief Executive Officer & Director from 2002.
Mr. Cornellier also founded Seyvika Pharmaceuticals.
Mr. Cornellier also formerly worked at 9342-8530 Québec, Inc., as Director, LAB International, Inc., as Senior Vice President-Business Development, Theratechnologies, Inc., as VP-Business Development & Commercialization, Miles Laboratories, Inc., as Principal, Abbott Laboratories Ltd., as Senior Marketing Manager, and Glaxo Canada, Inc., as Principal.
Yves Cornellier active positions
Companies | Position | Start |
---|---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Founder | 2001-12-31 |
Former positions of Yves Cornellier
Companies | Position | End |
---|---|---|
Miles Laboratories, Inc.
Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Corporate Officer/Principal | - |
Glaxo Canada, Inc. | Corporate Officer/Principal | - |
Abbott Laboratories Ltd.
Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Sales & Marketing | - |
THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
9342-8530 QUÉBEC INC. | Health Technology |
THERATECHNOLOGIES INC. | Health Technology |
Private companies | 6 |
---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
Seyvika Pharmaceuticals
Seyvika Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Seyvika Pharmaceuticals researches and develops drugs for the treatment of asthma. The company is based in Montréal, Canada. The Canadian company was founded by Yves Cornellier. Seyvika Pharmaceuticals was acquired by LAB International, Inc. on October 02, 2003 for $2.23 million. | Commercial Services |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
Abbott Laboratories Ltd.
Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Health Technology |
Miles Laboratories, Inc.
Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Health Technology |
Glaxo Canada, Inc. |
- Stock Market
- Insiders
- Yves Cornellier